No significant benefit of sacubitril/valsartan after acute MI: PARADISE-MI trial Medha Baranwal25 Oct 2021 10:00 AM ISTUSA: Sacubitril/valsartan does not significantly reduce the risk of heart failure (HF) or cardiovascular (CV) death for immediate post-myocardial...
Women with PCOS at increased risk of cardiovascular events, study finds Medha Baranwal21 Sept 2021 11:30 AM ISTUK: A recent study has pointed that young women with polycystic ovary syndrome (PCOS) are at an increased risk of angina, heart attack, and...
Study supports use of implantable cardiac monitors in selected post-infarction patients Dr. Kamal Kant Kohli7 Sept 2021 9:00 AM ISTSophia Antipolis: Remote monitoring of implantable cardiac monitors (ICMs) is highly effective for early detection of serious arrhythmias in...
No apparent benefit of Multivessel PCI among older STEMI patients: Study Dr. Shravani Dali31 Aug 2021 9:00 AM ISTMultivessel percutaneous coronary intervention (MV PCI) is not much beneficial for all older patients with ST-segment–elevation myocardial...
Admission hyperglycemia in MI patients may increase risk of death and adverse CV events: Study Medha Baranwal23 Aug 2021 11:45 AM ISTIran: Non-diabetic patients with a diagnosis of first-ever myocardial infarction (MI) admitted to hospital with stress hyperglycemia are at increased...
CK-MB based SCAI definition better defines outcomes of periprocedural MI, JACC study. dr. Abhimanyu Uppal13 Aug 2021 10:30 AM ISTThe magnitude of postprocedural biomarker elevation representing a clinically meaningful peri-procedural MI (PMI) after percutaneous coronary...
COVID-19 infection increases risk of stroke and heart attack: Lancet Study Medha Baranwal5 Aug 2021 9:00 AM ISTSweden: COVID-19 may independently increase the risk for ischemic stroke and acute myocardial infarction, a recent study has suggested.The findings,...
Multivessel PCI guided by FFR not superior to angiography for STEMI patients: Study Medha Baranwal21 July 2021 6:15 PM ISTDelhi: A fractional flow reserve (FFR) guided strategy is of no significant benefit over an angiography-guided strategy for STEMI patients undergoing...
Relevance of post-MI use of beta-blockers and MRA, reveals new study Medha Baranwal20 July 2021 9:00 AM ISTUSA: The effects of beta-blocker therapy on survival after myocardial infarction (MI), when analyzed dichotomously, on (all doses) did not demonstrate...
Crushed Prasugrel significantly Lowers Platelet Activity In Patients undergoing PCI: Study MD Bureau6 July 2021 10:30 AM ISTWhen crushed Prasugrel is administered to patients with suspected STEMI, it significantly lowered the platelet activity.
Researchers devise new surgical technique that can repair ruptures caused by heart attack Hina Zahid2 July 2021 9:00 AM ISTThe results showed that the procedure had an impressive 100% success rate. Also, compared to a bleak 10% survival rate if managed conservatively,...
P2Y12 inhibitor monotherapy 3 months after PCI sufficient to lower CV mortality: BMJ Medha Baranwal21 Jun 2021 10:00 AM ISTBern, Switzerland: The use of P2Y12 inhibitor monotherapy versus DAPT is associated with a similar risk of stroke, myocardial infarction, and death,...
